Table 5.

Ongoing registered clinical trials assessing the effect of endourological procedures on renal injury using biomarkers

NCT numberStudy designStudy populationEndourological techniqueBiomarkerTime points of renal function assessmentStatus and estimated completion date
NCT02522689Two parallel-arms, open- label randomized clinical study60 participants (30 per group) with renal stone <2 cmUltra-mini PCNL versus micro-PCNLCystatin C (blood, urine)Preoperative versus 12 h post-operative
  • Recruiting

  • 9/2021

NCT02522676Six parallel-arms, open-label randomized clinical study300 (50 per group) participants with lower pole and/or renal pelvis stone(s)PCNL versus mini-PCNL versus ultramini-PCNL versus micro-PCNL versus RIRS versus ESWL
  • Cystatin C (blood, urine)

  • Netrin-1 (blood, urine)

  • NGAL (urine)

Preoperative versus 6-, 12-, 24-, 48- and 72-h post-operative
  • Not yet recruiting

  • 9/2023

NCT03112499Three parallel-arms, open-label randomized clinical study75 (25 per group) participants with renal stone 1–3 cmPCNL versus mini-PCNL versus RIRS
  • NGAL (urine)

  • KIM-1 (urine)

  • IL-18 (urine)

2-h preoperative and 2, 6, 24 and 48 h post-operative
  • Recruiting

  • 7/2020

NCT numberStudy designStudy populationEndourological techniqueBiomarkerTime points of renal function assessmentStatus and estimated completion date
NCT02522689Two parallel-arms, open- label randomized clinical study60 participants (30 per group) with renal stone <2 cmUltra-mini PCNL versus micro-PCNLCystatin C (blood, urine)Preoperative versus 12 h post-operative
  • Recruiting

  • 9/2021

NCT02522676Six parallel-arms, open-label randomized clinical study300 (50 per group) participants with lower pole and/or renal pelvis stone(s)PCNL versus mini-PCNL versus ultramini-PCNL versus micro-PCNL versus RIRS versus ESWL
  • Cystatin C (blood, urine)

  • Netrin-1 (blood, urine)

  • NGAL (urine)

Preoperative versus 6-, 12-, 24-, 48- and 72-h post-operative
  • Not yet recruiting

  • 9/2023

NCT03112499Three parallel-arms, open-label randomized clinical study75 (25 per group) participants with renal stone 1–3 cmPCNL versus mini-PCNL versus RIRS
  • NGAL (urine)

  • KIM-1 (urine)

  • IL-18 (urine)

2-h preoperative and 2, 6, 24 and 48 h post-operative
  • Recruiting

  • 7/2020

Table 5.

Ongoing registered clinical trials assessing the effect of endourological procedures on renal injury using biomarkers

NCT numberStudy designStudy populationEndourological techniqueBiomarkerTime points of renal function assessmentStatus and estimated completion date
NCT02522689Two parallel-arms, open- label randomized clinical study60 participants (30 per group) with renal stone <2 cmUltra-mini PCNL versus micro-PCNLCystatin C (blood, urine)Preoperative versus 12 h post-operative
  • Recruiting

  • 9/2021

NCT02522676Six parallel-arms, open-label randomized clinical study300 (50 per group) participants with lower pole and/or renal pelvis stone(s)PCNL versus mini-PCNL versus ultramini-PCNL versus micro-PCNL versus RIRS versus ESWL
  • Cystatin C (blood, urine)

  • Netrin-1 (blood, urine)

  • NGAL (urine)

Preoperative versus 6-, 12-, 24-, 48- and 72-h post-operative
  • Not yet recruiting

  • 9/2023

NCT03112499Three parallel-arms, open-label randomized clinical study75 (25 per group) participants with renal stone 1–3 cmPCNL versus mini-PCNL versus RIRS
  • NGAL (urine)

  • KIM-1 (urine)

  • IL-18 (urine)

2-h preoperative and 2, 6, 24 and 48 h post-operative
  • Recruiting

  • 7/2020

NCT numberStudy designStudy populationEndourological techniqueBiomarkerTime points of renal function assessmentStatus and estimated completion date
NCT02522689Two parallel-arms, open- label randomized clinical study60 participants (30 per group) with renal stone <2 cmUltra-mini PCNL versus micro-PCNLCystatin C (blood, urine)Preoperative versus 12 h post-operative
  • Recruiting

  • 9/2021

NCT02522676Six parallel-arms, open-label randomized clinical study300 (50 per group) participants with lower pole and/or renal pelvis stone(s)PCNL versus mini-PCNL versus ultramini-PCNL versus micro-PCNL versus RIRS versus ESWL
  • Cystatin C (blood, urine)

  • Netrin-1 (blood, urine)

  • NGAL (urine)

Preoperative versus 6-, 12-, 24-, 48- and 72-h post-operative
  • Not yet recruiting

  • 9/2023

NCT03112499Three parallel-arms, open-label randomized clinical study75 (25 per group) participants with renal stone 1–3 cmPCNL versus mini-PCNL versus RIRS
  • NGAL (urine)

  • KIM-1 (urine)

  • IL-18 (urine)

2-h preoperative and 2, 6, 24 and 48 h post-operative
  • Recruiting

  • 7/2020

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close